中华眼科杂志
中華眼科雜誌
중화안과잡지
Chinese Journal of Ophthalmology
2010年
8期
719-724
,共6页
侯光辉%叶楠%吴静%徐锦堂%施文建%陈义%刘小浩%张泽华
侯光輝%葉楠%吳靜%徐錦堂%施文建%陳義%劉小浩%張澤華
후광휘%협남%오정%서금당%시문건%진의%류소호%장택화
间质干细胞%细胞分化%角膜%上皮样细胞%组织工程
間質榦細胞%細胞分化%角膜%上皮樣細胞%組織工程
간질간세포%세포분화%각막%상피양세포%조직공정
Mesenchymal stem cells%Cell differentiation%Comeal%Epithelioid cells%Tissue engineering
目的 应用猪板层角膜做载体将人骨髓间充质干细胞(human bone marrow mesenchymal stem cells,hMSC)跨胚层诱导为上皮样细胞,甚至角膜上皮样细胞,初步探讨hMSC作为构建组织工程角膜种子细胞的可行性.方法 实验研究.用密度梯度离心培养技术结合贴壁培养法分离纯化hMSC并传代,对体外培养的hMSC进行免疫表型鉴定.将传代后的hMSC接种于去上皮的猪角膜基质片前弹力层表面培养诱导分化,免疫荧光检测角膜上皮细胞标志物角蛋白12(CK12)以及角膜缘干细胞标记物ABCG2和CK19的表达.运用体外培养的方法使种植在前弹力层表面的细胞复层化.待细胞融合形成单层后,置入插入式培养皿中进行气液界面培养.培养4周后进行HE染色及免疫组织化学检测,光镜下观察其复层情况.结果 获得的hMSC可以在体外培养扩增,表现出很强的增殖潜能.流式细胞仪示:培养的hMSC CD45阳性率为0.06%,CD34为0.41%,CD44为86.43%,CD29为85.72%,CD105为90.72%.诱导4周后部分细胞表达CK12和CK19,不表达ABCG2.运用气液界面培养法进行体外复层的结果显示可以形成1~2层的上皮样细胞,并很可能为角膜上皮样细胞.结论 在本实验的诱导条件下,hMSC可以分化为上皮样细胞,并很可能为角膜上皮样细胞,hMSC有可能作为组织工程技术角膜上皮重建的种子细胞的选择.
目的 應用豬闆層角膜做載體將人骨髓間充質榦細胞(human bone marrow mesenchymal stem cells,hMSC)跨胚層誘導為上皮樣細胞,甚至角膜上皮樣細胞,初步探討hMSC作為構建組織工程角膜種子細胞的可行性.方法 實驗研究.用密度梯度離心培養技術結閤貼壁培養法分離純化hMSC併傳代,對體外培養的hMSC進行免疫錶型鑒定.將傳代後的hMSC接種于去上皮的豬角膜基質片前彈力層錶麵培養誘導分化,免疫熒光檢測角膜上皮細胞標誌物角蛋白12(CK12)以及角膜緣榦細胞標記物ABCG2和CK19的錶達.運用體外培養的方法使種植在前彈力層錶麵的細胞複層化.待細胞融閤形成單層後,置入插入式培養皿中進行氣液界麵培養.培養4週後進行HE染色及免疫組織化學檢測,光鏡下觀察其複層情況.結果 穫得的hMSC可以在體外培養擴增,錶現齣很彊的增殖潛能.流式細胞儀示:培養的hMSC CD45暘性率為0.06%,CD34為0.41%,CD44為86.43%,CD29為85.72%,CD105為90.72%.誘導4週後部分細胞錶達CK12和CK19,不錶達ABCG2.運用氣液界麵培養法進行體外複層的結果顯示可以形成1~2層的上皮樣細胞,併很可能為角膜上皮樣細胞.結論 在本實驗的誘導條件下,hMSC可以分化為上皮樣細胞,併很可能為角膜上皮樣細胞,hMSC有可能作為組織工程技術角膜上皮重建的種子細胞的選擇.
목적 응용저판층각막주재체장인골수간충질간세포(human bone marrow mesenchymal stem cells,hMSC)과배층유도위상피양세포,심지각막상피양세포,초보탐토hMSC작위구건조직공정각막충자세포적가행성.방법 실험연구.용밀도제도리심배양기술결합첩벽배양법분리순화hMSC병전대,대체외배양적hMSC진행면역표형감정.장전대후적hMSC접충우거상피적저각막기질편전탄력층표면배양유도분화,면역형광검측각막상피세포표지물각단백12(CK12)이급각막연간세포표기물ABCG2화CK19적표체.운용체외배양적방법사충식재전탄력층표면적세포복층화.대세포융합형성단층후,치입삽입식배양명중진행기액계면배양.배양4주후진행HE염색급면역조직화학검측,광경하관찰기복층정황.결과 획득적hMSC가이재체외배양확증,표현출흔강적증식잠능.류식세포의시:배양적hMSC CD45양성솔위0.06%,CD34위0.41%,CD44위86.43%,CD29위85.72%,CD105위90.72%.유도4주후부분세포표체CK12화CK19,불표체ABCG2.운용기액계면배양법진행체외복층적결과현시가이형성1~2층적상피양세포,병흔가능위각막상피양세포.결론 재본실험적유도조건하,hMSC가이분화위상피양세포,병흔가능위각막상피양세포,hMSC유가능작위조직공정기술각막상피중건적충자세포적선택.
Objective To investigate the differentiation potential of human bone marrow mesenchymal stem cells (hMSC) inducing into epithelial-like cells, even comeal epithelial-like cells, and to discuss the plasticity that make hMSC the seed cells used in comeal tissue engineering. Methods hMSC were isolated and purified by density gradient centrifugation combined with an attachment culture method and passaged in vitro. hMSC were identified by flow cytometry. The passaged hMSC were planted on fresh pig comeal Bowman's membrane. The expression of CK12, ABCG2 and CK19 in hMSC was identified by immunofluorescence staining. We used in vitro method to obtain a multilayer culture of hMSC. When hMSC formed a monolayer, the cells were inserted to Millicell culture and grew into multilauers by using the airlifting cultivation methodology. Four weeks later, after fixed and dehydrated, the hMSC were observed under the light microscope after hemotoxylin and eosin (HE) and immunohistochemistry staining. Results hMSC could be cultured, expanded in vitro, and showed great potential of proliferation. The result of flow cytometry showed that the positive staining percentage was 0.06% for CD45, 0.41% for CD34, 86.43% for CD44, 85.72% for CD29 and 90.72% for CD105. This indicated that hMSC expressed CD44, CD29, CD105 but not CD45 and CD34. After four weeks induction, part of hMSC expressed CK12 and CK19 but not ABCC2. In the in vitro stratification, HE and immunohistochemical staining showed that there were one or two layers epithelial-like cells, even corneal epithelial-like cells after using the air-lifting cultivation. Conclusions This study suggests that hMSC have the potential to differentiate into epithelial cells, even corneal epithelial cells. hMSC could be the option of cells used to reconstruct the comeal epithelium by tissue engineering technology.